uncategorized

February 4, 2021February 4, 2021

International Epilepsy Day Shines Spotlight on Brain Disorder Affecting Millions

uncategorized

International Epilepsy Day (IED), falling on Feb. 8 this year, calls attention to the needs of the roughly 50 million people globally who are affected by the brain disorder. “This ... Read more

February 1, 2021February 11, 2021

Jazz Acquires GW Pharma and Epidiolex, Other Potential Cannabinoids

uncategorized

Jazz Pharmaceuticals announced the signing of a definitive agreement for it to acquire GW Pharmaceuticals and holdings that include Epidiolex, an approved oral cannabinoid treatment for seizures in Lennox-Gastaut syndrome (LGS) patients. “We are ... Read more

January 28, 2021January 28, 2021

Study Reveals Molecular Details of Epidiolex Action

uncategorized

Cannabidiol (CBD) — the active ingredient in Epidiolex — was found to bind to and block the opening of the sodium channel protein associated with seizures in people with Lennox-Gastaut ... Read more

January 21, 2021January 21, 2021

Telehealth Visits Viewed Favorably in French Study for Children With Epilepsy

uncategorized

Telehealth visits — conferencing with patients via video or phone calls — are generally viewed favorably by both the treating physicians and the parents of children with epileptic conditions like ... Read more

January 7, 2021January 7, 2021

FDA Approves Generic of Banzel as Add-on Seizure Therapy

uncategorized

The U.S. Food and Drug Administration (FDA) has approved Lupin Limited’s generic medication, Rufinamide Oral Suspension, to be used as an add-on therapy to control seizures in adults and children, ... Read more

December 17, 2020December 17, 2020

Fintepla Found to Safely Reduce LGS Seizure Frequency

uncategorized

Fintepla (fenfluramine) safely lowered the frequency of drop seizures — those where part or all of the body may become limp — in patients with Lennox-Gastaut syndrome (LGS), according to ... Read more

December 10, 2020December 10, 2020

New Hard-Stop Alert for Clinicians May Reduce Keto Diet Prescription Errors

uncategorized

Researchers have developed a new “hard-stop alert” that pops up when clinicians are trying to prescribe carbohydrate-containing medications to hospitalized children on a keto diet — a ketogenic eating plan ... Read more

December 3, 2020December 3, 2020

Epidiolex’s Anti-Seizure Activity Not Affected by Clobazam, Review Study Finds

uncategorized

When given as an add-on therapy, Epidiolex (cannabidiol, CBD) can lower the frequency of seizures in young patients with Dravet and Lennox‐Gastaut syndromes — regardless of whether the children also ... Read more

November 19, 2020November 19, 2020

Epidiolex-treated LGS Boy Has No Seizures, Near-normal EEG Pattern, Case Study Reports

uncategorized

Adding Epidiolex, an oral cannabidiol medication, to other treatments successfully stopped epileptic seizures in a boy with Lennox-Gastaut syndrome (LGS), resulting in nearly normal electrical activity in the brain, a real-world case ... Read more

November 12, 2020November 12, 2020

Epilepsy Awareness Month Calls Attention to Seizure Disorders, Dravet, LGS

uncategorized

National Epilepsy Awareness Month is underway, with a variety of events and activities aimed at calling attention to diseases such as Dravet and Lennox-Gastaut syndromes, and to epilepsy in general. ... Read more